In addition, robust quantitative analyses were performed based on the Algorithm Intensity Index plus the average nuclear area percentage, confirming a positive correlation in terms of MEOX2-GLI1 axis co-expression levels for each lung cancer patient at both the p≤0.05 and p≤0.0001 significance levels (Figure 8C). The gene discussed is MEOX2; the disease is lung carcinoma.